186 related articles for article (PubMed ID: 29200876)
1. Effects of insulin analogs and glucagon-like peptide-1 receptor agonists on proliferation and cellular energy metabolism in papillary thyroid cancer.
He L; Zhang S; Zhang X; Liu R; Guan H; Zhang H
Onco Targets Ther; 2017; 10():5621-5631. PubMed ID: 29200876
[TBL] [Abstract][Full Text] [Related]
2. Expression of glucagon-like Peptide-1 receptor in papillary thyroid carcinoma and its clinicopathologic significance.
Jung MJ; Kwon SK
Endocrinol Metab (Seoul); 2014 Dec; 29(4):536-44. PubMed ID: 25559577
[TBL] [Abstract][Full Text] [Related]
3. Expression characteristics of proteins of IGF-1R, p-Akt, and survivin in papillary thyroid carcinoma patients with type 2 diabetes mellitus.
Yan Y; Hu F; Wu W; Ma R; Huang H
Medicine (Baltimore); 2017 Mar; 96(12):e6393. PubMed ID: 28328831
[TBL] [Abstract][Full Text] [Related]
4. GLP-1R polymorphism (rs1042044) and expression are associated with the risk of papillary thyroid cancer among the Egyptian population.
Abdul-Maksoud RS; Elsayed WSH; Rashad NM; Elsayed RS; Elshorbagy S; Hamed MG
Gene; 2022 Aug; 834():146597. PubMed ID: 35598685
[TBL] [Abstract][Full Text] [Related]
5. Glucagon-like peptide-1 increases beta-cell glucose competence and proliferation by translational induction of insulin-like growth factor-1 receptor expression.
Cornu M; Modi H; Kawamori D; Kulkarni RN; Joffraud M; Thorens B
J Biol Chem; 2010 Apr; 285(14):10538-45. PubMed ID: 20145256
[TBL] [Abstract][Full Text] [Related]
6. Glucagon-like peptide-1 receptor mediated control of cardiac energy metabolism.
Al Batran R; Almutairi M; Ussher JR
Peptides; 2018 Feb; 100():94-100. PubMed ID: 29412838
[TBL] [Abstract][Full Text] [Related]
7. Anti-diabetic actions of glucagon-like peptide-1 on pancreatic beta-cells.
Lee YS; Jun HS
Metabolism; 2014 Jan; 63(1):9-19. PubMed ID: 24140094
[TBL] [Abstract][Full Text] [Related]
8. Liraglutide, a glucagon-like peptide-1 receptor agonist, facilitates osteogenic proliferation and differentiation in MC3T3-E1 cells through phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT), extracellular signal-related kinase (ERK)1/2, and cAMP/protein kinase A (PKA) signaling pathways involving β-catenin.
Wu X; Li S; Xue P; Li Y
Exp Cell Res; 2017 Nov; 360(2):281-291. PubMed ID: 28919123
[TBL] [Abstract][Full Text] [Related]
9. Exendin-4 enhances proliferation of senescent osteoblasts through activation of the IGF-1/IGF-1R signaling pathway.
Zhang M; Xie Y; Zhou Y; Chen X; Xin Z; An J; Hou J; Chen Z
Biochem Biophys Res Commun; 2019 Aug; 516(1):300-306. PubMed ID: 31256933
[TBL] [Abstract][Full Text] [Related]
10. GLP-1 receptor agonist liraglutide inhibits the proliferation and migration of thyroid cancer cells.
Zhang X; Zhang L; Wang B; Zhang X; Gu L; Guo K; Zhang X; Zhou Z
Cell Mol Biol (Noisy-le-grand); 2023 Dec; 69(14):221-225. PubMed ID: 38279433
[TBL] [Abstract][Full Text] [Related]
11. Glucagon-like peptide-1 receptor activation inhibits growth and augments apoptosis in murine CT26 colon cancer cells.
Koehler JA; Kain T; Drucker DJ
Endocrinology; 2011 Sep; 152(9):3362-72. PubMed ID: 21771884
[TBL] [Abstract][Full Text] [Related]
12. Activation of glucagon-like peptide-1 receptor signaling does not modify the growth or apoptosis of human pancreatic cancer cells.
Koehler JA; Drucker DJ
Diabetes; 2006 May; 55(5):1369-79. PubMed ID: 16644694
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-486 inhibits cell proliferation, invasion and migration via down-regulating the TENM1 expressions and affecting ERK and Akt signaling pathways and epithelial-to-mesenchymal transition in papillary thyroid carcinoma.
Sun YH; Liu ZF; Yang BB; Yu B
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8429-8439. PubMed ID: 31646573
[TBL] [Abstract][Full Text] [Related]
14. GLP-1 signals via ERK in peripheral nerve and prevents nerve dysfunction in diabetic mice.
Jolivalt CG; Fineman M; Deacon CF; Carr RD; Calcutt NA
Diabetes Obes Metab; 2011 Nov; 13(11):990-1000. PubMed ID: 21635674
[TBL] [Abstract][Full Text] [Related]
15. Should we still be concerned about the potential side effects of glucagon-like peptide-1 receptor agonists on thyroid C cells?
Cao Y; Liu XM
Endocrine; 2015 Feb; 48(1):47-52. PubMed ID: 25033998
[TBL] [Abstract][Full Text] [Related]
16. Insulin and IGF-1 receptor autocrine loops are not required for Exendin-4 induced changes to pancreatic β-cell bioenergetic parameters and metabolism in BRIN-BD11 cells.
Rowlands J; Cruzat V; Carlessi R; Newsholme P
Peptides; 2018 Feb; 100():140-149. PubMed ID: 29412813
[TBL] [Abstract][Full Text] [Related]
17. Exendin-4 induces a novel extended effect of ischemic tolerance via crosstalk with IGF-1R.
Zhang H; Liu Y; Cheng L; Ma X; Luo X
Brain Res Bull; 2021 Apr; 169():145-155. PubMed ID: 33197537
[TBL] [Abstract][Full Text] [Related]
18. Expression and significance of IGF-1 and IGF-1R in thyroid nodules.
Liu YJ; Qiang W; Shi J; Lv SQ; Ji MJ; Shi BY
Endocrine; 2013 Aug; 44(1):158-64. PubMed ID: 23288662
[TBL] [Abstract][Full Text] [Related]
19. Progesterone receptor membrane component 1 is a functional part of the glucagon-like peptide-1 (GLP-1) receptor complex in pancreatic β cells.
Zhang M; Robitaille M; Showalter AD; Huang X; Liu Y; Bhattacharjee A; Willard FS; Han J; Froese S; Wei L; Gaisano HY; Angers S; Sloop KW; Dai FF; Wheeler MB
Mol Cell Proteomics; 2014 Nov; 13(11):3049-62. PubMed ID: 25044020
[TBL] [Abstract][Full Text] [Related]
20. Tanshinone IIA Attenuates Insulin Like Growth Factor 1 -Induced Cell Proliferation in PC12 Cells through the PI3K/Akt and MEK/ERK Pathways.
Wang H; Su X; Fang J; Xin X; Zhao X; Gaur U; Wen Q; Xu J; Little PJ; Zheng W
Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30213025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
